MedTrace Logo

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

NCT02164019 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are looking to see if differences exist (after surgery) in function, quality of life, pain control, and possible complications.

Conditions

  • Proximal Femoral Metastases

Interventions

PROCEDURE

long-stem cemented hemiarthroplasty (LSCH)

PROCEDURE

intramedullary nailing (IMN)

BEHAVIORAL

questionnaires

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    collaborator OTHER

  • Spectrum Health Medical Group

    collaborator UNKNOWN

  • University of Rochester

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Walter Reed National Military Medical Center

    collaborator FED

  • Duke University

    collaborator OTHER

  • Montefiore Medical Center

    collaborator OTHER

  • Medical University of Graz

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • John Healey, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02164019 on ClinicalTrials.gov